'A solid pharmaceutical comprising human growth hormone (hGH) and N-(5- chlorosalicyloyl)-8- aminocaprylic acid (5- CNAC)'

摘要

The present invention relates to dosage forms of human growth hormone, the use of an absorption enhancer to allow absorption of human growth hormone into the systemic circulation in a biologically active form, in particular after oral administration, as well as the use of oral dosage forms comprising human growth hormone and an absorption enhancer for the treatment of human growth hormone deficiencies and disorders associated therewith. WO2008027854A2